Production (Stage)
CalciMedica, Inc.
CALC
$1.75
$0.052.94%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -26.33% | 60.12% | 52.81% | 52.95% | 36.38% |
Total Depreciation and Amortization | -3.33% | 0.00% | 21.15% | 13.21% | 15.38% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 2.37% | -179.32% | -214.69% | -241.74% | -201.91% |
Change in Net Operating Assets | 113.62% | -85.39% | 87.90% | 20.03% | -203.15% |
Cash from Operations | 15.07% | 17.82% | 24.50% | 16.08% | -86.04% |
Capital Expenditure | 78.21% | 89.74% | 92.31% | 100.00% | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 183.84% | -149.26% | -116.56% | -193.42% | -287.18% |
Cash from Investing | 182.92% | -149.79% | -116.72% | -193.92% | -288.82% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -48.60% | 164.32% | 84.72% | 86.53% | 86.24% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -99.99% | -99.99% | -121.72% |
Cash from Financing | 19.75% | 33.85% | -26.60% | -30.69% | -48.65% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 132.90% | -40.68% | -121.58% | -174.37% | -175.82% |